SPONSOR
University of Illinois at Chicago
Total Trials
13
Recruiting
13
Phases
Phase 2, Phase 4
Conditions studied: Pregnancy ComplicationsMaternal Care PatternsPatient EngagementMultiple SclerosisMultiple Sclerosis (MS) - Relapsing-remittingMultiple Sclerosis (MS) Primary ProgressiveMultiple Sclerosis (MS) Secondary ProgressiveMultiple Sclerosis Acute and ProgressiveAcute LeukemiaMDS
University of Illinois at Chicago is a clinical research sponsor with 13 registered studies on ClinicalTrials.gov, of which 13 are actively recruiting participants. Research covers conditions including Pregnancy Complications, Maternal Care Patterns, Patient Engagement, Multiple Sclerosis.
The trial portfolio spans Phase 2, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University of Illinois at Chicago
How many clinical trials has University of Illinois at Chicago sponsored?
ClinicalMetric currently tracks 13 clinical trials sponsored by University of Illinois at Chicago, of which 13 are actively recruiting participants. These trials cover conditions including Pregnancy Complications, Maternal Care Patterns, Patient Engagement. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of Illinois at Chicago research focus on?
University of Illinois at Chicago clinical trials span Pregnancy Complications, Maternal Care Patterns, Patient Engagement, Multiple Sclerosis, Multiple Sclerosis (MS) - Relapsing-remitting, and additional conditions. The research pipeline includes Phase 2, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of Illinois at Chicago clinical trial?
To participate in a University of Illinois at Chicago trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Illinois at Chicago trials with current recruitment status updated daily.
Clinical Trials by University of Illinois at Chicago
NCT05365815
Recruiting
Melanated Group Midwifery Care (MGMC)
Pregnancy Complications
NCT07355387
Recruiting
Home Based Functional Balance Intervention for Multiple Sclerosis
Multiple Sclerosis
NCT04187105 Phase 2
Recruiting
BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI)
Acute Leukemia
NCT05792852
Recruiting
Improving the Health and Social Participation of People With Disabilities From Underrepresented Groups Post COVID
Disabilities Multiple
NCT06296836 Phase 4
Recruiting
Effect of Continuing Versus Holding Metformin During Hospitalizations.
Diabetes Mellitus, Type 2
NCT06555627
Recruiting
Embracing Morning BReakfast and Activity for Classroom Engagement
Child Development
NCT07175051 Phase 2
Recruiting
Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin
Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0)
NCT06241300
Recruiting
Executive Function and Parenting in Childhood
Disruptive Behavior Disorder, Childhood Onset
NCT04891068 Phase 2
Recruiting
BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer
Breast Cancer Invasive
NCT04205279
Recruiting
Reactive Balance Training for Fall Prevention
Healthy Young
NCT07387445
Recruiting
Feasibility and Acceptibility of a Multi-site Trial of Time Restircted Eating During Chemotheraply for Breast Cancer.
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
NCT06886477
Recruiting
Sickle Cell, Pain and Mediterranean Diet
Sickle Cell
NCT05208164
Recruiting
My ESSENCE - A Research Study on Mindfulness for African-Americans With Type 2 Diabetes
Type 2 Diabetes
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology